The Adeno-1™ Expression System provides an efficient method
for constructing
recombinant adenoviruses. Our procedure uses in
vitro ligation to subclone your
gene of interest into a
replication!
incompetent (-E1/-E3) human adenoviral type 5 (Ad5)
genome.
This approach enables you to produce
recombinant adenoviruses
quickly (less than 3 weeks) and reliably. Our pShuttle vectors (+/-)
have very flexible
cloning sites, which allow easy subcloning
manipulation.
Cloning your gene of interest into the pShuttle (+/-):
1. Subclone your
gene of interest into the pShuttle(+/-) using any of
the unique restriction sites located in the
MCS region.
2.
PI-Sce I/I-Ceu I digestion of
recombinant pshuttle and adeno
DNA
a. Prepare a 30ul
PI-Sce I/I-Ceu I double-digest of your pShuttle
and adeno
DNA.
b. Combine the reagents shown in Table 2 in a sterile 1.5 ml
c. Mix well and spin briefly to collect liquid.
d.
Incubate at 37ºC for exactly 3 hours.
e. Perform phenol:chloroform:isoamyl alcohol (25:24:1)
extraction by using the protocol in Appendix A.
Table 2.
PI-Sce I/I-Ceu I Double-Digest of pShuttle and pAdeno
DNA
Sterile H2O x ul
Total Volume 30ul
Produce recombinant adenoviral DNA:
1. Subclone your expression cassette into the Adeno
genome:
a. Combine the reagents shown in Table 3 in a sterile 1.5 ml
microcentrifuge tube in the order as shown.
d. To the ligation product, add the following:
- 1.5 ul 10X Swa I digestion
Buffer
- 1.0 ul ddH2O
f. Perform phenol:chloroform:isoamyl alcohol (25:24:1)
extraction by using the protocol in Appendix A.
Table 3. Ligation of pShuttle to Adenovector
Reagent Volume
PI-Sce I/I-Ceu I digested
vector 4ul
PI-Sce I/I-Ceu I digested pShuttle 3ul
Total Volume 10ul
2. Transform
E.coli with ligation products
a. Transform electro! or chemically competent DH5alpha or our Ad-
competent (Cat No. DA014)
cells with the Swa I digestion product.
b. Select for ampicillin-resistant (Ampr) transformants by plating
the transformation mixture on a LB agar/
Amp plate (100 ug/ml ampicillin).
Incubate overnight at 37ºC.
c. Pick up 10 colonies and inoculate into 100 ul LB/
Amp medium
in a sterile Eppendorf
tube in the early morning.
d. After 5-6 hours of incubation, screen for positive clones using
PCR with Adeno
screening primer mix (using the protocol in
Appendix B).
e. When you have identified a bacterial clone carrying the
g. Purify the
plasmid using our
Column Pure
Plasmid Maxi-Prep
Kit (Cat No DD205) or the Qiagen kits. Expected yield: 30-50 ug
plasmid DNA/100 ml culture.
Note: pAdeno is a large
plasmid (>30 kb) that is susceptible to damage and
3. Analyze putative
recombinant Adenoviral
DNA by
PCR or
restriction digestion
a. Set up 30ul
PI-Sce I/I-Ceu I double digests by combining the
reagents in Table 4 in a sterile 1.5 ml
microcentrifuge tube.
b. Mix well and spin briefly to collect contents.
c.
Incubate at 37ºC for exactly 3 hours.
PI-Sce I (1 unit/ul) 2ul
I-Ceu I (1 unit/ul) 2ul
ddH2O x ul
Total Volume 30ul
You can also screen pAdeno
DNA for the presence of pShuttle
derived expression cassettes by using
PCR with Adeno forward
the
cloning site in pAdeno. Only
recombinant pAdenoviral
templates are amplified since non!recombinants lack the pShuttle
4. Preparing
Recombinant Adenoviral
DNA for
Transfection
b. Mix contents and spin the
tube briefly.
c.
Incubate at 37ºC for 2 hours
d. Perform phenol extractions by using the protocol in
Appendix A.
Pac I (10 units/ul) 2ul
ddH2O x ul
Total Volume 40ul
maintained at 5% CO2.
5. Check periodically for cytopathic effect (CPE). Note: It
normally takes 7-12 days to see CPE.
6. When >90% of the
cells have detached from the
plate, prepare
viral stock by following steps 7-10. Name this stock “Primary
Amplification” and store at –20ºC.
- Primary
Amplification Stock is suitable for infecting
target
cells. We suggest you evaluate the function of this
viral stock before preparing High-Titer Stock.
- The presence of your
recombinant construct can be
7.
Centrifuge the suspension at 1,500 x g for 5 min at room
10. After the third cycle, briefly
centrifuge to pellet debris.
11. Determine the adenoviral titer. The Adenovector™ Rapid Titer
Infecting target cells:
If the
viruses are to be used in
in vitro cell cultures, Double CsCl
purification is not required as the
viral supernatant will provide
100%
gene transduction efficiency in most human
cell lines. For in
vivo studies (i.e.
animal studies),
purification is essential to remove
defective particles,
cell debris, and small amounts of
media
components, since these contaminants can induce significant
immune responses. In addition, CsCl
purification will concentrate
the
virus to a level suitable for
in vivo injections.
http://www.capitalbiosciences.com